Introduction
The 3-Hydroxy-3-Methylglutaryl Coenzyme A (HMG-CoA) reductase inhibitors or statins are widely used in the primary and secondary prevention of cardiovascular events (1).
Statins are usually well-tolerated and do not have many serious side effects. One of the side effects that can affect the decision to continue treatment with statins is musculoskeletal complications such as tendinopathy, which is most common with Atorvastatin and Simvastatin (2).
Statin-related musculoskeletal adverse effects (AE) vary from mild myalgia and muscle weakness to tendinopathy and rhabdomyolysis (1). The probable risk factors summarized in table 1. Tendinopathy is usually presented with tendinitis and tendon rupture, especially of the Achilles, quadriceps, and distal biceps tendons, which mostly happen within the first year of initiation and improve after discontinuation (3).
In this case report, we described a 58-years old man who experience tendon rupture as an adverse effect of using statin.